Joint Corp expected to post a loss of 2 cents a share - Earnings Preview
Joint Corp
JYNT is expected to show a fall in quarterly revenue when it reports results on August 7 for the period ending June 30 2025
The Scottsdale Arizona-based company is expected to report a 56.0% decrease in revenue to $13.321 million from $30.26 million a year ago, according to the mean estimate from 5 analysts, based on LSEG data.
LSEG's mean analyst estimate for Joint Corp is for a loss of 2 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell."
The average consensus recommendation for the healthcare facilities & services peer group is also "Buy".
Wall Street's median 12-month price target for Joint Corp is $15.50, about 27.9% above its last closing price of $11.18
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Mar. 31 2025 | 0.00 | 0.00 | -0.03 | Missed | |
Dec. 31 2025 | 0.01 | 0.06 | Beat | 500 | |
Sep. 30 2024 | 0.04 | 0.01 | -0.21 | Missed | -2,725 |
Jun. 30 2024 | -0.02 | -0.02 | -0.13 | Missed | -630.3 |
Mar. 31 2024 | 0.00 | -0.01 | 0.06 | Beat | 1,100 |
Dec. 31 2023 | 0.01 | 0.01 | -0.75 | Missed | -6,350 |
Sep. 30 2023 | 0.01 | 0.02 | -0.05 | Missed | -377.8 |
Jun. 30 2023 | 0.01 | -0.01 | Missed | -200 |
This summary was machine generated August 5 at 21:39 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)